SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma

Figure 2

Assessment of the relationship between solute carrier family 41 family gene expression and pathological cancer stage in LIHC patients using the GEPIA database. (a) Highly expressed SLC41A1 exhibited a significant relationship with high pathological carcinoma stage. (b) The relationship between the expression of SLC41A2 and pathological carcinoma stage. (c) Highly expressed SLC41A3 displayed an obvious association with high pathological carcinoma stage.

(a)

(b)

(c)